摘要 |
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of removing and preferably storing a portion of the patient's blood, intravenously administering a biocompatible liquid in sufficient quantity to substantially maintain the patient's hemodynamic stability, wherein the liquid comprises an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier, after which the patient undergoes a loss of blood, and then readministering blood to the patient, preferably the stored blood. In one embodiment, the biocompatible liquid further comprises a hemodiluent and the hemodiluent is administered separately from the oxygen carrier. |
申请人 |
ALLIANCE PHARMACEUTICAL CORP., SAN DIEGO, CALIF., US |
发明人 |
ROTH, DUANE J., LA JOLLA, CA 92037, US;KEIPERT, PETER E., SAN DIEGO, CA 92130, US;FAITHFUL, NICOLAS SIMON, NORMANTON BY BOTTESFORD NG13 0EP, GB;ZUCK, THOMAS F., CINCINNATI, OH 45244, US;RIESS, JANE G., F-06950 NICE, FR |